PALONOSETRON Teva sol inj 0.25 mg/5ml flac
7680686710016
CH-68671
A04AA05
01.09.0.
Reimbursement limitations:
EMETCHEMOTHE
Chimiothérapie fortement émétogène.
1 / 3
google
Details
- Product number
- 6867101
- CPT
- -
- Packaging group
- 1
- Unit
- Durchstechflasche(n)
- Composition
- palonosetronum 0.25 mg ut palonosetroni hydrochloridum, mannitolum, dinatrii edetas, acidum citricum monohydricum, natrii citras dihydricus, natrii hydroxidum, acidum hydrochloridum, aqua ad iniectabile q.s. ad solutionem pro 5 ml corresp., natrium 5,8 mg.
Articles (1)
Palonosetron-Teva 0.25 mg/5 ml, Injektionslösung
Injektionslösung
1
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.25 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HBESI |
Reimbursement information
Public price
CHF 60.75
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/10/2022
Authorization holder
Teva Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68671
- Drug name
- Palonosetron-Teva, Injektionslösung
- Galenic form
- LSINJ
- ATC Code
- A04AA05
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 08/07/2022
- Authorization expiration date
- 07/07/2027
- IT number
- 01.09.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- PALONOSETRON Teva sol inj 0.25 mg/5ml flac
- Description (DE)
- PALONOSETRON Teva Inj Lös 0.25 mg/5ml Durchstf
- Market launch
- 08/07/2022
- Narcotic (BTM)
- No